Should Anti-TNF-α therapy be offered to patients with infertility and recurrent spontaneous abortion?

American Journal of Reproductive Immunology

Volumn 61, Issue 2, 2009, Pages 107-112

  Clark, David A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; GAMMA INTERFERON; HEPARIN; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADVISORY COMMITTEE; ARTICLE; CELLULAR IMMUNITY; CLINICAL RESEARCH; EMOTIONAL DISORDER; EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; GENETIC RISK; GENOTYPE; HEALTH CARE POLICY; HLA TYPING; HUMAN; IMMUNOMODULATION; INFERTILITY; INFORMED CONSENT; KARYOTYPE; LICENSING; MEDICAL ETHICS; NONHUMAN; OFF LABEL DRUG USE; PRACTICE GUIDELINE; PREGNANCY RATE; PRIORITY JOURNAL; RECURRENT ABORTION; REPRODUCTIVE SUCCESS; SPONTANEOUS ABORTION; TH1 CELL; TH2 CELL; TREATMENT RESPONSE;

ABORTION, HABITUAL; ANIMALS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFERTILITY, FEMALE; MICE; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58249136199     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00680.x     Document Type: Article

References (40)

1. Wallis RS: Tumour necrosis facSor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008; 8:601-611.
2. Menges T, Konig IR, Hossain H, Little S, Tchatalbachev S, Thierer F, Hackstein H, Frantjkovic I, Colaris T, Martens F, Weismuller K, Langerfeld T, Stricker J, Hempelmann G, Vos PE, Ziegler A, Jacobs B, Chakraborty T, Bein G: Sepsis syndrome and death in trauma patients are associated with variation in the gene coding tumor necrosis factor. Crit Care Med 2008; 36:1456-1462.
3. Montagna P, Capellino S, Villaggio B, Remorgida V, Ragni N, Cutolo M, Ferrero S: Peritoneal fluid macrophages iC endometriosis: correlation between the expression of estrogen receptors and inflammation. Fertil Steril 2008; 90:156-164.
4. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas E, Mangubat CP, Beaman KD, Beer AE, Gillman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy loss and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
5. Winger EE, Reed J, Ashoush S, Sapna A, El-Toukhy T, Teranissi M: Treatment with adalimumab (Humira) and intravenous immunoglobulin (IVIG) improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
6. Winger EE, Reed JL: Treatment with tumor necrosis factor inhibitors improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60: 8-16.
7. Chaouat G: Comment: Primum non-Nocere. Am J Reprod Immunol 2008; 60:17-18.
8. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG: Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447-458.
9. Arck PC, Trout AB, Clark DA: Soluble receptors neutralizing TNF-α and IL-1 block stress-triggered murine abortion. Am J Reprod Immunol 1997; 37:262-266.
10. Recurrent Miscarriage Immunotherapy Trialists Group (RMITG): Worldwide collaborative observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:55-72.
11. Clark DA, Coulam CB, Daya S, Chaouat G: Unexplained sporadic and recurrent miscarriage in the new millennium: A critical analysis of immune mechanisms and treatments. Hum Reprod Update 2001; 7:501-511.
12. Clark DA: Immunological factors in preFnancy wastage: fact or fiction. Am J Reprod Immunol 2008; 59:277-300.
13. Benson K, Hartz AJ: A comparison of observational studies and randomized controlled trials. N Engl J Med 2000; 342:1878-1886.
14. Concato J, Shah N, Horowitz RI: Randomized controlled trials, observational studies, and hierarchy of research designs. N Engl J Med 2000; 342:1887-1892.
15. Straus S, Haynes B, Glasziou P, Dickerson K, Guyatt G: Misunderstandings, misperceptions, and mistakes. Evid Based Med 2007; 12:2-3.
16. Concato J: Observational studies versus experWmental studies: what's the evidence for a hierarchy? NeuroRx 2004; 1:341-347.
17. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ: Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 136(6 Suppl):123S-131S.
18. Clark DA: Shall we properly re-examine the status of allogeneic lymphocyte therapy for recurrent early pregnancy failure? Am J Reprod Immunol 2004; 51:7-15.
19. van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA: Decline in number of elevated blood CD3 CD56 NKT cells in response to IVIG treatment correlates with successful pregnancy. Am J Reprod Immunol 2007; 58:447-459.
20. Chaouat G: Should we re-examine the status of lymphocyte alloimmunization therapy for recurrent spontaneous abortion? Am J Reprod Immunol 2003; 50:433-438.
21. Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee SK, Beaman K: Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failure. Fertil Steril 2008; 89:157-165.
22. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA: The cutting edge: cytokine dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J Immunol 1998; 162:545-549.
23. Clark DA, Arck PC, Chaouat G: Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level Am J Reprod Immunol 1999; 41:5-22.
24. Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM: MD-1 is a critical part of the mechanism causing Th-1 cytokine-triggered murine fetal loss syndrome. Am J Reprod Immunol 2003; 49:297-307.
25. Giese A, Stuhlsatz S, Daubner W, MacKenzie CR: Inhibition of the growth of Toxoplasma gondii in immature dendritic cells is dependent on the expression of TNF-α receptor 2. J Immunol 2004; 173:3366-3374.
26. Lansley T: Technical Information Services. Bar Harbor, ME, The Jackson Laboratory, 2008. email: Micetechψax,org
27. Hiby SE, Walkeer JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale A, Moffet A: Combination of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-965.
28. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffet A: Association of maternal killer-cell immunoglobulin-like receptors and paternal HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008; 23:972-976.
29. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
30. CIark DA, Daya S, Coulam CB, Gunby J: RMITG: implications of abnormal trophoblast karyotype of the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:495-498.
31. Brosens JJ, Pijneborg R, Brosens AI: The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: A review of the literature. Am J Obstet Gynecol 2002; 187:1416-1423.
32. Michel MZ, Khong TY, Clark DA, Beard RW: A morphological and immunological study of human placental bed biopsies in miscarriage. Br J Obstet Gynaecol 1990; 97:984-988.
33. Robillard PY, Hulsey TC, Perianin J, Janky E, Miri EH, Papiernik E: Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344:973-975.
34. Clark DA: Does immunological intercourse prevent pre-eclampsia? Lancet 1994; 344:868-869.
35. Clark DA: Tolerance signaling molecules. Chem Immunol Allergy 2005; 89:36-48.
36. Clark DA: Hard science versus phenomenology in reproductive immunology. Crit Rev Immunol 1999; 19:509-539.
37. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Parcj PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:1450-1457.
38. Karimi K, Blois SM, Arck PC: The upside of natural killers. Nat Med 2008; 14: 1184-1185
39. + regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy. Drug Discov Today 2007; 12:548-552.
40. Nadkarni S, Mauri C, Ehrenstein MR: Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. N Engl J Med 2007; 204:33-39.